Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;264(1):112-120.
doi: 10.1007/s00415-016-8304-z. Epub 2016 Oct 27.

Botulinum Toxin Therapy for Treatment of Spasticity in Multiple Sclerosis: Review and Recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders Task Force

Affiliations
Review

Botulinum Toxin Therapy for Treatment of Spasticity in Multiple Sclerosis: Review and Recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders Task Force

Dirk Dressler et al. J Neurol. .

Abstract

Botulinum toxin (BT) therapy is an established treatment of spasticity due to stroke. For multiple sclerosis (MS) spasticity this is not the case. IAB-Interdisciplinary Working Group for Movement Disorders formed a task force to explore the use of BT therapy for treatment of MS spasticity. A formalised PubMed literature search produced 55 publications (3 randomised controlled trials, 3 interventional studies, 11 observational studies, 2 case studies, 35 reviews, 1 guideline) all unanimously favouring the use of BT therapy for MS spasticity. There is no reason to believe that BT should be less effective and safe in MS spasticity than it is in stroke spasticity. Recommendations include an update of the current prevalence of MS spasticity and its clinical features according to classifications used in movement disorders. Immunological data on MS patients already treated should be analysed with respect to frequencies of MS relapses and BT antibody formation. Registration authorities should expand registration of BT therapy for spasticity regardless of its aetiology. MS specialists should consider BT therapy for symptomatic treatment of spasticity.

Keywords: Botulinum toxin; IAB-Interdisciplinary Working Group for Movement Disorders; Multiple sclerosis; Recommendations; Review; Spasticity; Therapeutic use.

Similar articles

See all similar articles

Cited by 4 articles

References

    1. Clin Rehabil. 2013 Sep;27(9):803-12 - PubMed
    1. Curr Opin Microbiol. 2012 Jun;15(3):325-36 - PubMed
    1. Ann Readapt Med Phys. 2003 Jul;46(6):299-302 - PubMed
    1. Drugs. 2011 May 28;71(8):1043-58 - PubMed
    1. Neurochirurgie. 2003 May;49(2-3 Pt 2):265-70 - PubMed

MeSH terms

Substances

LinkOut - more resources

Feedback